Literature DB >> 32419981

Incidence of low back pain and sacroiliitis in military families with acne vulgaris under isotretinoin therapy.

Alahyar Taheri1, Sadegh Sabouhi1, Farzaneh Farazmand2.   

Abstract

BACKGROUND: Acne vulgaris is a common complication that patients referred to dermatologist, also there are medications to manage of this such as isotretinoin, and incidence of low back pain in these patients is more than general population, so in this study we aimed to evaluate of Incidence of low back pain and sacroiliitis in military families with acne vulgaris under isotretinoin therapy.
METHODS: This cross-sectional study was performed on 113 acne vulgaris patients treated with isotretinoin (at least 3 months) referred to dermatology clinic of Imam Reza Hospital of Army Medical Sciences, Tehran, Iran during 2018 to 2019. All data of patients such as dosage and duration of medication, severity of acne, incidence of low back pain, sacroiliitis and inflammatory back pain and lab data were recorded.
RESULTS: 54% of patients had lethargy, 41.6% had myalgia and 46.9% had low back pain. Of the patients with low back pain, 54.7% had inflammatory low back pain and 45.3% had mechanical low back pain. 29 cases had inflammatory low back pain, 5 cases had sacroiliitis and one case had positive RF, the means of ESR, CRP and ANA were 19.01 ± 12.74 Mm/hr, 3.43 ± 1.27 Mg/litr and 1.31 ± 0.90, respectively.
CONCLUSION: In patients with acne vulgaris under isotretinoin therapy much attention must be given regarding to sacroiliitis and rheumatoid diseases especially when symptoms such as low back pain are present. AJCEI
Copyright © 2020.

Entities:  

Keywords:  Acne vulgaris; isotretinoin; low back pain; rheumatoid diseases; sacroiliitis

Year:  2020        PMID: 32419981      PMCID: PMC7218680     

Source DB:  PubMed          Journal:  Am J Clin Exp Immunol


  12 in total

1.  Acute hip monoarthritis in a patient treated with isotretinoin.

Authors:  Teresa Pedraz; Agustín Martínez; Eliseo Pascual
Journal:  J Clin Rheumatol       Date:  2006-04       Impact factor: 3.517

Review 2.  Rheumatological symptoms due to retinoids.

Authors:  G Kaplan; B Haettich
Journal:  Baillieres Clin Rheumatol       Date:  1991-04

3.  Isotretinoin associated reversible hypothyroidism.

Authors:  Muhammad Qamar Masood; Haris Hakeem
Journal:  Thyroid       Date:  2011-08-11       Impact factor: 6.568

Review 4.  Oral Isotretinoin: New Developments Relevant to Clinical Practice.

Authors:  Jerry Tan; Sanwarjit Boyal; Karishma Desai; Sanja Knezevic
Journal:  Dermatol Clin       Date:  2016-04       Impact factor: 3.478

5.  Isotretinoin-induced arthritis mimicking both rheumatoid arthritis and axial spondyloarthritis.

Authors:  Ozlem Yilmaz Tasdelen; Fatma Gul Yurdakul; Semra Duran; Hatice Bodur
Journal:  Int J Rheum Dis       Date:  2014-10-08       Impact factor: 2.454

6.  The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.

Authors:  Leyla Baykal Selçuk; Deniz Aksu Arıca; Hanife Baykal Şahin; Savas Yaylı; Sevgi Bahadır
Journal:  Cutan Ocul Toxicol       Date:  2016-11-16       Impact factor: 1.820

7.  Sacroiliitis secondary to isotretinoin.

Authors:  Michele Levinson; Andrew Gibson; Gemma Stephenson
Journal:  Australas J Dermatol       Date:  2011-12-29       Impact factor: 2.875

Review 8.  Arthritis precipitated by isotretinoin treatment for acne vulgaris.

Authors:  R A Hughes
Journal:  J Rheumatol       Date:  1993-07       Impact factor: 4.666

9.  Creatine phosphokinase values during isotretinoin treatment for acne.

Authors:  Yesim Kaymak
Journal:  Int J Dermatol       Date:  2008-04       Impact factor: 2.736

Review 10.  Acute sacroiliitis.

Authors:  Gleb Slobodin; Doron Rimar; Nina Boulman; Lisa Kaly; Michael Rozenbaum; Itzhak Rosner; Majed Odeh
Journal:  Clin Rheumatol       Date:  2016-02-04       Impact factor: 2.980

View more
  2 in total

1.  Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: A cross-sectional study.

Authors:  Emine Müge Acar; Senem Şaş; Fatmanur Aybala Koçak
Journal:  Arch Rheumatol       Date:  2021-12-24       Impact factor: 1.007

2.  Analysis of musculoskeletal side effects of oral Isotretinoin treatment: a cross-sectional study.

Authors:  Nermin Karaosmanoğlu; Cevriye Mülkoğlu
Journal:  BMC Musculoskelet Disord       Date:  2020-09-25       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.